Aspen Aerogels Q4 2023 GAAP EPS $(0.01) Beats $(0.12) Estimate, Sales $84.22M Beat $80.86M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aspen Aerogels (ASPN) reported Q4 2023 earnings with a GAAP EPS of $(0.01), surpassing the $(0.12) estimate. Sales reached $84.22M, exceeding the $80.86M forecast, marking a 41.28% increase from the previous year.
February 12, 2024 | 9:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aspen Aerogels reported a significant beat on both EPS and sales estimates for Q4 2023, with a notable year-over-year sales growth.
Beating both EPS and sales estimates significantly, especially by a margin of 91.67% for EPS, indicates strong financial health and operational efficiency. This outperformance, coupled with a substantial year-over-year sales increase, is likely to instill investor confidence and could lead to a positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100